Company / Net Debt per Share
Eton Pharmaceuticals, Inc. Net Debt per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Debt per Share
-$0.16
FY2025
5-year range
-$0.88 / $0.59
FY2021-FY2025
Trend
-127.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Net Debt per Share has fluctuated over the past 7 years, ranging from $-0.88 in FY2023 to $0.59 in FY2024.
Based on SEC 10-K filings.
-0.16 in FY2025.
Increased from $-0.88 to $-0.16 over the past 2 years.
Net Debt per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, net debt per share decreased 127.7% year-over-year.
- Peak net debt per share was recorded in FY2024.
- Lowest net debt per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score 0.63 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.16 | -127.7% |
| FY2024 | $0.59 | +166.7% |
| FY2023 | -$0.88 | -98.4% |
| FY2022 | -$0.44 | -17.9% |
| FY2021 | -$0.38 | +54.5% |
| FY2020 | -$0.83 | -93.2% |
| FY2019 | -$0.43 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026